Skip to main content
logo
Medigen Biotechnology Corp. (TPEX:3176)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.75
+0.20 (0.70%)
Sep 17, 2025, 1:30 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Generic Drug, Aesthetic Medicine Product and Dietary Supplement
695.08M
Log In
Log In
Log In
Log In
Upgrade
Generic Drug, Aesthetic Medicine Product and Dietary Supplement Growth
-1.97%
Log In
Log In
Log In
Log In
Upgrade
New Drug and Vaccine Research and Development
605.64M
Log In
Log In
Log In
Log In
Upgrade
New Drug and Vaccine Research and Development Growth
55.44%
Log In
Log In
Log In
Log In
Upgrade
Nucleic Acid
62.53M
Log In
Log In
Log In
Log In
Upgrade
Nucleic Acid Growth
5.91%
Log In
Log In
Log In
Log In
Upgrade
Cytotherapy
9.45M
Log In
Log In
Log In
Log In
Upgrade
Cytotherapy Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Taiwan
1.34B
Log In
Log In
Log In
Log In
Upgrade
Taiwan Growth
17.25%
Log In
Log In
Log In
Log In
Upgrade
Other Countries
23.99M
Log In
Log In
Log In
Log In
Upgrade
Other Countries Growth
383.88%
Log In
Log In
Log In
Log In
Upgrade
China
4.44M
Log In
Log In
Log In
Log In
Upgrade
China Growth
-29.42%
Log In
Log In
Log In
Log In
Upgrade